<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T04:50:41Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/16888" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/16888</identifier><datestamp>2026-10-18T20:41:07Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Effects of Mirtazapine on Liver Ischemia-Reperfusion Injury in Rats</dc:title><dc:creator>Alemdar, Ali</dc:creator><dc:creator>Yilmaz, Ismayil</dc:creator><dc:creator>Ozcicek, Fatih</dc:creator><dc:creator>Bulut, Seval</dc:creator><dc:creator>Eden, Arif Onur</dc:creator><dc:creator>Gursul, Cebrail</dc:creator><dc:creator>Mendi, Ali Sefa</dc:creator><dc:creator>Kuzucu, Mehmet</dc:creator><dc:creator>Altuner, Durdu</dc:creator><dc:creator>Suleyman, Halis</dc:creator><dc:subject>Ischemia reperfusion injury</dc:subject><dc:subject>liver</dc:subject><dc:subject>mirtazapine</dc:subject><dc:subject>rats</dc:subject><dc:subject>INDUCED OXIDATIVE STRESS</dc:subject><dc:subject>ISCHEMIA/REPERFUSION INJURY</dc:subject><dc:subject>DAMAGE</dc:subject><dc:subject>INFLAMMATION</dc:subject><dc:subject>PROTECTS</dc:subject><dc:subject>EDEMA</dc:subject><dc:subject>MODEL</dc:subject><dc:subject>Pharmacology &amp; Pharmacy</dc:subject><dc:description>Background and Objective: Ischemia-reperfusion (I/R) injury begins with tissue oxygen deprivation and continues with oxidative stress and inflammatory response. Mirtazapine is an antidepressant drug with antioxidant and anti-inflammatory properties. The current study was to investigate the effect of mirtazapine against I/R induced liver injury in rats. Materials and Methods: Albino Wistar-type male rats were divided into sham operation (SHAM), I/R (IR) and I/R+mirtazapine administrated (IRM) groups. One hour before anaesthesia, 20 mg kg(-1) mirtazapine was administered to the IRM group of the animals and distilled water was applied to the SHAM and IR groups as a solvent. I/R was achieved by clamping the hepatic artery (except for the SHAM group). Following I/R, all rat groups were killed with high-dose anaesthesia. Malondialdehyde (MDA), total glutathione (tGSH), nuclear factor kappa B (NF-kappa B), interleukin 1 beta (IL-1 beta) and tumour necrosis factor-alpha (TNF-alpha) were determined in liver tissues. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were measured in blood serum. In addition, histopathological examination was performed on liver tissue samples. Results: Mirtazapine prevented increased levels of MDA, NF-kappa B, IL-1 beta, TNF-alpha, ALT and AST in liver tissue with I/R and a decrease in tGSH. Furthermore, mirtazapine has alleviated I/R-associated severe hepatocyte degeneration, necrosis and other structural disorders in the liver. Conclusion: Biochemical and histopathological experimental results suggest that mirtazapine may be useful in the treatment of I/R-induced liver injury.</dc:description><dc:publisher>ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET</dc:publisher><dc:date>2022</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/16888</dc:identifier><dc:identifier>https://doi.org/10.3923/ijp.2022.1093.1100</dc:identifier><dc:identifier>1811-7775</dc:identifier><dc:language>en</dc:language><dc:relation>INTERNATIONAL JOURNAL OF PHARMACOLOGY</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/16888</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>